Richard  Buchholz net worth and biography

Richard Buchholz Biography and Net Worth

Rick Buchholz has served as Chief Financial Officer since May 2014. Prior to joining Inspire, Mr. Buchholz served as the Chief Financial Officer, Secretary, and Treasurer at superDimension, Ltd., a medical device manufacturer (which was acquired by Covidien plc in 2012), from 2006 to 2013. Mr. Buchholz holds a B.B.A. from the University of Wisconsin, Eau Claire and is a Certified Public Accountant (inactive).

What is Richard Buchholz's net worth?

The estimated net worth of Richard Buchholz is at least $5.33 million as of April 17th, 2024. Mr. Buchholz owns 28,271 shares of Inspire Medical Systems stock worth more than $5,334,738 as of December 3rd. This net worth evaluation does not reflect any other investments that Mr. Buchholz may own. Additionally, Mr. Buchholz receives a salary of $663,430.00 as CFO at Inspire Medical Systems. Learn More about Richard Buchholz's net worth.

How old is Richard Buchholz?

Mr. Buchholz is currently 56 years old. There are 8 older executives and no younger executives at Inspire Medical Systems. The oldest executive at Inspire Medical Systems is Mr. Timothy P. Herbert, CEO, President & Director, who is 61 years old. Learn More on Richard Buchholz's age.

What is Richard Buchholz's salary?

As the CFO of Inspire Medical Systems, Inc., Mr. Buchholz earns $663,430.00 per year. There are 2 executives that earn more than Mr. Buchholz. The highest earning executive at Inspire Medical Systems is Mr. Timothy P. Herbert, CEO, President & Director, who commands a salary of $1,360,000.00 per year. Learn More on Richard Buchholz's salary.

How do I contact Richard Buchholz?

The corporate mailing address for Mr. Buchholz and other Inspire Medical Systems executives is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. Inspire Medical Systems can also be reached via phone at (844) 672-4357 and via email at [email protected]. Learn More on Richard Buchholz's contact information.

Has Richard Buchholz been buying or selling shares of Inspire Medical Systems?

Richard Buchholz has not been actively trading shares of Inspire Medical Systems over the course of the past ninety days. Most recently, Richard Buchholz sold 15,000 shares of the business's stock in a transaction on Wednesday, April 17th. The shares were sold at an average price of $230.03, for a transaction totalling $3,450,450.00. Following the completion of the sale, the chief financial officer now directly owns 28,271 shares of the company's stock, valued at $6,503,178.13. Learn More on Richard Buchholz's trading history.

Who are Inspire Medical Systems' active insiders?

Inspire Medical Systems' insider roster includes Randy Ban (Insider), Richard Buchholz (CFO), Philip Ebeling (COO), Jerry Griffin (Director), Timothy Herbert (CEO), Steven Jandrich (VP), Chau Khuong (Director), Georgia Melenikiotou (Director), Marilyn Nelson (Director), John Rondoni (CTO), and Casey Tansey (Director). Learn More on Inspire Medical Systems' active insiders.

Are insiders buying or selling shares of Inspire Medical Systems?

In the last year, insiders at the sold shares 12 times. They sold a total of 82,063 shares worth more than $16,763,484.79. The most recent insider tranaction occured on September, 9th when Director Shawn Mccormick sold 800 shares worth more than $176,000.00. Insiders at Inspire Medical Systems own 4.1% of the company. Learn More about insider trades at Inspire Medical Systems.

Information on this page was last updated on 9/9/2024.

Richard Buchholz Insider Trading History at Inspire Medical Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/17/2024Sell15,000$230.03$3,450,450.0028,271View SEC Filing Icon  
1/13/2023Sell11,977$250.03$2,994,609.3134,387View SEC Filing Icon  
1/11/2023Sell523$250.00$130,750.0046,364View SEC Filing Icon  
4/1/2022Sell15,000$258.67$3,880,050.0047,176View SEC Filing Icon  
12/15/2020Sell3,000$190.53$571,590.00
11/17/2020Sell3,000$171.66$514,980.0071,551View SEC Filing Icon  
10/20/2020Sell3,000$122.84$368,520.0072,951View SEC Filing Icon  
9/22/2020Sell6,000$126.09$756,540.0071,884View SEC Filing Icon  
7/21/2020Sell3,000$99.37$298,110.00View SEC Filing Icon  
6/23/2020Sell12,000$97.25$1,167,000.00View SEC Filing Icon  
8/19/2019Sell4,000$66.86$267,440.00View SEC Filing Icon  
7/16/2019Sell4,000$68.34$273,360.00View SEC Filing Icon  
6/17/2019Sell4,000$56.37$225,480.00View SEC Filing Icon  
5/20/2019Sell4,000$50.05$200,200.00View SEC Filing Icon  
4/16/2019Sell4,000$56.05$224,200.00View SEC Filing Icon  
3/20/2019Sell2,000$56.25$112,500.00View SEC Filing Icon  
2/20/2019Sell2,000$56.87$113,740.00View SEC Filing Icon  
1/22/2019Sell6,000$54.18$325,080.00View SEC Filing Icon  
5/7/2018Buy4,750$16.00$76,000.00View SEC Filing Icon  
See Full Table

Richard Buchholz Buying and Selling Activity at Inspire Medical Systems

This chart shows Richard Buchholz's buying and selling at Inspire Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inspire Medical Systems Company Overview

Inspire Medical Systems logo
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Read More

Today's Range

Now: $193.41
Low: $187.13
High: $194.62

50 Day Range

MA: $197.40
Low: $172.85
High: $214.91

2 Week Range

Now: $193.41
Low: $123.00
High: $257.40

Volume

104,017 shs

Average Volume

592,905 shs

Market Capitalization

$5.80 billion

P/E Ratio

180.76

Dividend Yield

N/A

Beta

1.31